ES2072492T3 - Derivados de acido piridinalqueno- y -aminooxialcano-carboxilico sustituidos por fenilsulfonamida. - Google Patents

Derivados de acido piridinalqueno- y -aminooxialcano-carboxilico sustituidos por fenilsulfonamida.

Info

Publication number
ES2072492T3
ES2072492T3 ES91113089T ES91113089T ES2072492T3 ES 2072492 T3 ES2072492 T3 ES 2072492T3 ES 91113089 T ES91113089 T ES 91113089T ES 91113089 T ES91113089 T ES 91113089T ES 2072492 T3 ES2072492 T3 ES 2072492T3
Authority
ES
Spain
Prior art keywords
substituted
derivatives
piridinalqueno
fenilsulfonamida
aminooxialcano
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91113089T
Other languages
English (en)
Inventor
Ulrich Dr Niewohner
Ulrich E Dr Muller
Elisabeth Dr Perzborn
Erwin Dr Bischoff
Hans-Georg Dr Dellweg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Application granted granted Critical
Publication of ES2072492T3 publication Critical patent/ES2072492T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • C07D213/71—Sulfur atoms to which a second hetero atom is attached

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

DE ACUERDO CON ESTA INVENCION LOS COMPUESTOS PUEDEN SER FABRICADOS A TRAVES DE LA TRANSFORMACION DE LAS CORRESPONDIENTES AMINAS CON DERIVADOS DE ACIDO SULFONICO O EN EL CASO DE COMPUESTOS AMINOOXI A TRAVES DE TRANSFORMACION DE ACETONA CON COMPUESTOS AMINOOXI O ALQUILIZACION DE AMINAS HIDROXI O EN CASO DE COMPUESTOS ALQUENOS A TRAVES DE TRANSFORMACION DE ACETONA CON FOSFORILIDAS. LOS SUSTITUIDOS FENILSULFONAMIDAS PIRIDINALQUENOS ILIZADOS PARA EL TRATAMIENTO DE ENFERMEDADES TROMBOEMBOLICAS, ISQUIAMEN, ARTERIOESCLEROSIS, ALERGIAS Y ASMA.
ES91113089T 1990-08-16 1991-08-03 Derivados de acido piridinalqueno- y -aminooxialcano-carboxilico sustituidos por fenilsulfonamida. Expired - Lifetime ES2072492T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4025818A DE4025818A1 (de) 1990-08-16 1990-08-16 Phenylsulfonamid substituierte pyridinalken- und -aminooxyalkancarbonsaeure-derivate

Publications (1)

Publication Number Publication Date
ES2072492T3 true ES2072492T3 (es) 1995-07-16

Family

ID=6412268

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91113089T Expired - Lifetime ES2072492T3 (es) 1990-08-16 1991-08-03 Derivados de acido piridinalqueno- y -aminooxialcano-carboxilico sustituidos por fenilsulfonamida.

Country Status (7)

Country Link
US (1) US5155121A (es)
EP (1) EP0471259B1 (es)
JP (1) JPH04244063A (es)
AT (1) ATE122657T1 (es)
DE (2) DE4025818A1 (es)
DK (1) DK0471259T3 (es)
ES (1) ES2072492T3 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003208952B2 (en) * 2002-01-30 2008-04-24 Amgen Inc. Heterocyclic arylsulfonamidobenzylic compounds
EP2399903A1 (en) 2002-05-24 2011-12-28 Millennium Pharmaceuticals, Inc. Ccr9 inhibitors and methods of use thereof
AU2003298661B2 (en) * 2002-11-18 2007-05-10 Chemocentryx, Inc. Aryl sulfonamides
US7741519B2 (en) 2007-04-23 2010-06-22 Chemocentryx, Inc. Bis-aryl sulfonamides
US20070021466A1 (en) * 2002-11-18 2007-01-25 Solomon Ungashe CCR2 inhibitors and methods of use thereof
US7227035B2 (en) * 2002-11-18 2007-06-05 Chemocentryx Bis-aryl sulfonamides
US20060111351A1 (en) * 2002-11-18 2006-05-25 Solomon Ungashe Aryl sulfonamides
US7420055B2 (en) 2002-11-18 2008-09-02 Chemocentryx, Inc. Aryl sulfonamides
GB0316889D0 (en) * 2003-07-18 2003-08-20 Univ London Pharmaceutical agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3838120A (en) * 1972-12-07 1974-09-24 Sterling Drug Inc 1-alkyl-1h,4h-pyrido(2,3-d)(1,3)oxazine-2,4-diones and their conversion to 1-alkyl-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acids
US4518602A (en) * 1982-10-07 1985-05-21 Takeda Chemical Industries, Ltd. Vinyl carboxylic acid derivatives, their production and use as inhibitors of thromboxane synthetase
US4874775A (en) * 1985-06-11 1989-10-17 Eli Lilly And Company Agriculturally useful sulfonamides
AU610174B2 (en) * 1987-05-22 1991-05-16 E.R. Squibb & Sons, Inc. Phosphorus-containing hmg-coa reductase inhibitors, new intermediates and method
DE3932403A1 (de) * 1989-05-12 1991-04-11 Thomae Gmbh Dr K Neue arylsulfonamide, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
ATE122657T1 (de) 1995-06-15
DE59105500D1 (de) 1995-06-22
EP0471259B1 (de) 1995-05-17
US5155121A (en) 1992-10-13
EP0471259A1 (de) 1992-02-19
DE4025818A1 (de) 1992-02-20
JPH04244063A (ja) 1992-09-01
DK0471259T3 (da) 1995-09-11

Similar Documents

Publication Publication Date Title
NO924433L (no) Isoksazol-4-karboksylsyreamider og hydroksyalkyliden-cyaneddiksyreamider, legemidler inneholdende disse forbindelsene og deres anvendelse
DK0933993T3 (da) Substituerede cyclopentanforbindelser, der er egnede som neuraminidaseinhibitorer
BRPI0307351B8 (pt) composto, composição farmacêutica, uso de um composto, e, processo para preparar um composto
RO83309B (ro) Procedeu pentru prepararea (-)-n-metil-3-(2-metil-fenoxi)-3-fenilpropilaminei
BR9914696A (pt) Composto, processo para tratamento de distúrbio mediado por ciclo-oxigenase-2 em um indivìduo, e, composição farmacêutica
BR8606233A (pt) Processo para preparacao de 2,2-paraciclofano e seus derivados
EA200000759A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
FI913943A0 (fi) Nya kroman- och tiokromanderivat.
FI823860L (fi) 3-(1-substituerade-4-piperidyl)-1,2-bensisoxazoler, en process foer framstaellning daerav, en farmaceutisk komposition innehaollande dessa och deras anvaendning som laekemedel
PT93959A (pt) Processo para a preparacao de derivados de sacarina uteis como inibidores proteoliticos de enzima
BR8802066A (pt) Processo para preparacao de azois n-substituidos,especialmente imidazois n-substituidos
BR0206514A (pt) Composto, método de tratamento de um ser humano ou animal que sofre de enxaqueca, uso do composto, composição farmacêutica, e, processo para preparar um composto
ES2032955T3 (es) Sal sodica anhidra cristalina de 5-cloro-3-(2-tenoil)-2-oxindol-1-carboxamida.
SE8801275L (sv) New uses of dopamine agonists
DK0471259T3 (da) Phenylsulfonamid-substituerede pyridinalken- og -aminooxyalkancarboxylsyre-derivater
ATE128128T1 (de) Antiatherosclerotische und antithrombotische 2- amino-6-phenyl-4h-pyran-4-one.
FR2581382B1 (fr) Derives n-(quinolyl) glycinamides, leur procede de preparation et leur application therapeutique en tant que psychotropes
PT89478A (pt) Processo para a preparacao de piridinas di-substituidas
NO883846D0 (no) Anvendelse av polyaralkylaminer som korrosjonsinhibitorer, nye polyaralkylaminer og fremgangsmaate til deres fremstilling.
BR9507381A (pt) Composto uso de um composto processo para o tratamento de um manifero composição famacèutica e processo para a preparação de compostos
BR7806183A (pt) Processo para a diminuicao da concentracao de agentes nitrosantes em 1-cloro-2,6-dinitro-4-(trifluor-metil)benzeno
ES2169022T3 (es) Utilizacion de derivados de (piridil-metil-sulfinil)-1-h-bencimidazol para el tratamiento de enfermedades provocadas por helicobacter.
DK491984A (da) Diarylindan-1,3-dioner, fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse
ATE130304T1 (de) Neue alpha-glukosidaseinhibitoren.
ES2037003T3 (es) Procedimiento para preparar peptidos empleando percloratos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 471259

Country of ref document: ES